Capital Advisors Ltd’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11K Buy
122
+47
+63% +$4.45K ﹤0.01% 878
2026
Q2
$6K Hold
75
– – ﹤0.01% 950
2026
Q1
$7K Hold
75
– – ﹤0.01% 906
2025
Q4
$7K Sell
75
-122
-62% -$11.6K ﹤0.01% 893
2025
Q3
$19K Buy
197
+14
+8% +$1.39K ﹤0.01% 667
2025
Q2
$17K Buy
183
+100
+120% +$9.7K ﹤0.01% 676
2025
Q1
$9K Sell
83
-59
-42% -$6.31K ﹤0.01% 815
2024
Q4
$15K Buy
142
+67
+89% +$7.19K ﹤0.01% 691
2024
Q3
$8K Sell
75
-3
-4% -$327 ﹤0.01% 838
2024
Q2
$8K Sell
78
-6
-7% -$707 ﹤0.01% 810
2024
Q1
$11K Buy
84
+5
+6% +$625 ﹤0.01% 705
2023
Q4
$10K Buy
79
+1
+1% +$112 ﹤0.01% 697
2023
Q3
$9K Sell
78
-17
-18% -$2.16K ﹤0.01% 713
2023
Q2
$14K Buy
95
+1
+1% +$136 ﹤0.01% 637
2023
Q1
$12K Buy
94
+15
+19% +$1.88K ﹤0.01% 533
2022
Q4
$10K Buy
79
+52
+193% +$6.03K ﹤0.01% 568
2022
Q3
$3K Buy
+27
New +$2.96K ﹤0.01% 788
2022
Q2
– Sell
-100
Closed -$13K – 1372
2022
Q1
$13K Buy
100
+2
+2% +$241 ﹤0.01% 495
2021
Q4
$12K Buy
+98
New +$12.8K ﹤0.01% 506

Other funds holding ZBH

Capital Advisors Ltd's ZBH Position: Q3 2026 in Review

Capital Advisors Ltd increased its Zimmer Biomet (ZBH) stake by 63% in Q3 2026, buying an estimated $4.45K and bringing the position to 122 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #878.

Capital Advisors Ltd first reported a position in ZBH in Q4 2021 and has held it in 19 quarters since. The position peaked at $19K in Q3 2025. 778 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Capital Advisors Ltd held 122 shares of Zimmer Biomet worth $11K as of Q3 2026.
  • Capital Advisors Ltd bought 47 Zimmer Biomet shares in Q3 2026, an estimated $4.45K.
  • Zimmer Biomet made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q3 2026, its #878 holding.
  • Capital Advisors Ltd first reported a position in Zimmer Biomet in Q4 2021 and has held it in 19 quarters since.
  • Capital Advisors Ltd's Zimmer Biomet position peaked at $19K in Q3 2025.
  • 778 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Capital Advisors Ltd's 13F filing for Q3 2026, filed 27 Oct 2026.